AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34325532 — intervention group
Group type: EXPERIMENTAL
Intervention: True electroacupuncture
Number of subjects: 50
Study 34325532 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 50
Study 34325532 — intervention group
Group type: COMPARATOR
Intervention: Sham electroacupuncture
Number of subjects: 50
Study 34325532 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 50
Study 32154613 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (ATV) 10 mg
Number of subjects: 402
Study 32154613 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (ATV) 20 mg
Number of subjects: 402
Study 32154613 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (ATV) 30 mg
Number of subjects: 402
Study 32154613 — intervention group
Group type: COMPARATOR
Intervention: Control group (no atorvastatin)
Number of subjects: 402
Study 34881440 — intervention group
Group type: EXPERIMENTAL
Intervention: Bolus Gastric Feeding (BGF)
Number of subjects: 147
Study 34881440 — intervention group
Group type: COMPARATOR
Intervention: Continuous Gastric Feeding (CGF)
Number of subjects: 147
Study 35328854 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) engagement
Number of subjects: 1030
Study 35328854 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy
Number of subjects: 1030
Study 35328854 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI
Number of subjects: 1030
Study 32609274 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual selection of high-yielding passion fruit genotypes resistant to the Cowpea aphid-borne mosaic virus
Number of subjects: 5
Study 36141439 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented reality appliance (AR)
Number of subjects: 60
Study 36141439 — intervention group
Group type: COMPARATOR
Intervention: Manual (freehand) technique (MN)
Number of subjects: 60
Study 32049934 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram for predicting lung metastasis
Number of subjects: 580
Study 32049934 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher risk of lung metastasis group
Number of subjects: 580
Study 32049934 — intervention group
Group type: EXPERIMENTAL
Intervention: Independent factors influencing lung metastasis
Number of subjects: 580
Study 33941564 — intervention group
Group type: EXPERIMENTAL
Intervention: Siemens Atellica B.R.A.H.M.S PCT assay
Number of subjects: 45
Study 33941564 — intervention group
Group type: COMPARATOR
Intervention: Abbott Architect B.R.A.H.M.S PCT assay
Number of subjects: 45
Study 33941564 — intervention group
Group type: EXPERIMENTAL
Intervention: Both assays at clinically diagnostic cutoffs (0.1, 0.25, 0.5, 2.0 ng/mL)
Number of subjects: 45
Study 33941564 — intervention group
Group type: EXPERIMENTAL
Intervention: Bland-Altman analysis
Number of subjects: 45
Study 616388522 — intervention group
Group type: EXPERIMENTAL
Intervention: BRIGHT light exposure
Number of subjects: 72
Study 616388522 — intervention group
Group type: EXPERIMENTAL
Intervention: BLUE light exposure
Number of subjects: 72
Study 616388522 — intervention group
Group type: COMPARATOR
Intervention: CONTROL light exposure
Number of subjects: 72
Study 616388522 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to melanopic light
Number of subjects: 72
Study 35788169 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin
Number of subjects: 0
Study 35788169 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Number of subjects: 0
Study 35788169 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34370009 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-Reported Outcome Measurements (PROMS)
Number of subjects: 0
Study 34370009 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized algorithms for analyzing PROMS
Number of subjects: 0
Study 34370009 — intervention group
Group type: EXPERIMENTAL
Intervention: Integration of PROMS into cardiovascular interventions
Number of subjects: 0
Study 35282955 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month behavioral intervention using nudges and feedback to promote healthier choices, building on existing cafeteria traffic light labels.
Number of subjects: 510
Study 35282955 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month behavioral intervention for participants with lower health literacy.
Number of subjects: 510
Study 35282955 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 510
Study 35282955 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention overall.
Number of subjects: 510
Study 34164360 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine lactoferrin (bLf) 100 mg twice a day orally during antibiotic therapy
Number of subjects: 156
Study 34164360 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156
Study 34390076 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention adapted for social anxiety disorder (MBI-SAD)
Number of subjects: 97
Study 34390076 — intervention group
Group type: COMPARATOR
Intervention: Cognitive behaviour group therapy (CBGT)
Number of subjects: 97
Study 34390076 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment matching (preference for MBI-SAD or CBGT)
Number of subjects: 97
Study 34390076 — intervention group
Group type: EXPERIMENTAL
Intervention: Perception of treatment credibility
Number of subjects: 97
Study 34611208 — intervention group
Group type: COMPARATOR
Intervention: Pulsatile-release caffeine (160 mg)
Number of subjects: 22
Study 32830436 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteophyte resection (OR group)
Number of subjects: 41
Study 32830436 — intervention group
Group type: COMPARATOR
Intervention: Nonresection (NR group)
Number of subjects: 41
Study 32830436 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (OR and NR)
Number of subjects: 41
Study 34477880 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically increased leukocyte telomere length (LTL)
Number of subjects: 12488
Study 34477880 — intervention group
Group type: EXPERIMENTAL
Intervention: LTL associations at specific loci (3q26.2, 5p15.33, 10q24.33, 20q13.3)
Number of subjects: 12488
Study 34477880 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic variation involving PARP1, PRRC2A, CARMIL1, POT1, and ATM‐NPAT1
Number of subjects: 12488
Study 34702260 — intervention group
Group type: EXPERIMENTAL
Intervention: Submucosal approach
Number of subjects: 266
Study 34702260 — intervention group
Group type: COMPARATOR
Intervention: Subserosal approach
Number of subjects: 266
Study 34343632 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Training (FT)
Number of subjects: 108
Study 34343632 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent Training (CT)
Number of subjects: 108
Study 34343632 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 108
Study 32160205 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive management (behavioral intensification to measure BP at home by texting, direct telephone call, or breakthrough visit)
Number of subjects: 60
Study 32160205 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 60
Study 36394764 — intervention group
Group type: EXPERIMENTAL
Intervention: Study group (patients who developed pneumothorax)
Number of subjects: 240
Study 36394764 — intervention group
Group type: COMPARATOR
Intervention: Control group (patients who did not develop pneumothorax)
Number of subjects: 240
Study 36394764 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 240
Study 35997592 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-daily emollient application for the first 8 weeks of life
Number of subjects: 321
Study 35997592 — intervention group
Group type: COMPARATOR
Intervention: Standard routine skin care
Number of subjects: 321
Study 33517032 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined anodal tDCS and gait training with FES (tDCS+FES, n=11)
Number of subjects: 34
Study 33517032 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS with gait training (tDCS, n=11)
Number of subjects: 34
Study 33517032 — intervention group
Group type: COMPARATOR
Intervention: Combined sham tDCS and gait training with FES (FES, n=12)
Number of subjects: 34
Study 34056781 — intervention group
Group type: EXPERIMENTAL
Intervention: Active TENS (Quell®), N = 62, used for three months
Number of subjects: 119
Study 34056781 — intervention group
Group type: COMPARATOR
Intervention: Sham TENS, N = 57, used for three months
Number of subjects: 119
Study 34324836 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolised Ad5-nCoV high dose (HDmu group) - 2 × 10^10 viral particles
Number of subjects: 130
Study 34324836 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerosolised Ad5-nCoV low dose (LDmu group) - 1 × 10^10 viral particles
Number of subjects: 130
Study 34324836 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed vaccination (MIX group) - Initial intramuscular (5 × 10^10 viral particles) followed by aerosolised booster (2 × 10^10 viral particles)
Number of subjects: 130
Study 34324836 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular vaccination (1Dim group) - 5 × 10^10 viral particles
Number of subjects: 130
Study 34324836 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular vaccination (2Dim group) - 10 × 10^10 viral particles
Number of subjects: 130
Study 35467557 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold Forceps Polypectomy (CFP)
Number of subjects: 179
Study 35467557 — intervention group
Group type: COMPARATOR
Intervention: Cold Snare Polypectomy (CSP)
Number of subjects: 179
Study 33811762 — intervention group
Group type: EXPERIMENTAL
Intervention: TradAC/RC
Number of subjects: 40
Study 33811762 — intervention group
Group type: EXPERIMENTAL
Intervention: TradAC/XP
Number of subjects: 40
Study 33811762 — intervention group
Group type: EXPERIMENTAL
Intervention: UltraAC/XP
Number of subjects: 40
Study 33811762 — intervention group
Group type: EXPERIMENTAL
Intervention: TradAC/XP and UltraAC/XP
Number of subjects: 40
Study 33811762 — intervention group
Group type: EXPERIMENTAL
Intervention: UltraAC/RC
Number of subjects: 40
Study 33811762 — intervention group
Group type: EXPERIMENTAL
Intervention: UltraAC groups
Number of subjects: 40
Study 33811762 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 40
Study 33336222 — intervention group
Group type: COMPARATOR
Intervention: Withholding wellness education
Number of subjects: 272
Study 33336222 — intervention group
Group type: COMPARATOR
Intervention: Withholding yoga
Number of subjects: 272
Study 32304734 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine
Number of subjects: 112
Study 32304734 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study 35172792 — intervention group
Group type: EXPERIMENTAL
Intervention: High-translucent zirconia (Zr)
Number of subjects: 56
Study 35172792 — intervention group
Group type: EXPERIMENTAL
Intervention: Zirconium lithium silicate (ZLS)
Number of subjects: 56
Study 34749710 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual-based PA challenge
Number of subjects: 70
Study 34749710 — intervention group
Group type: EXPERIMENTAL
Intervention: Friend-based PA challenge
Number of subjects: 70
Study 34749710 — intervention group
Group type: EXPERIMENTAL
Intervention: Team-based PA challenge
Number of subjects: 70
Study 34749710 — intervention group
Group type: COMPARATOR
Intervention: General mood states
Number of subjects: 70
Study 33140384 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoballoon ablation during atrial fibrillation (AF group; n = 48)
Number of subjects: 195
Study 33140384 — intervention group
Group type: COMPARATOR
Intervention: Cryoballoon ablation during sinus rhythm (SR group; n = 147)
Number of subjects: 195
Study 33140384 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoballoon ablation during AF (AF group)
Number of subjects: 195
Study 33140384 — intervention group
Group type: COMPARATOR
Intervention: Cryoballoon ablation during SR (SR group)
Number of subjects: 195
Study 34449790 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori seropositivity
Number of subjects: 597
Study 34449790 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV seropositivity
Number of subjects: 597
Study 34449790 — intervention group
Group type: EXPERIMENTAL
Intervention: Age in HIV negative individuals
Number of subjects: 597
Study 34449790 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori (multivariable analysis)
Number of subjects: 597
Study 32571454 — intervention group
Group type: EXPERIMENTAL
Intervention: Early continuous blood purification (CBP)
Number of subjects: 58
Study 32571454 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 58
Study 35679810 — intervention group
Group type: EXPERIMENTAL
Intervention: Euhydration + Treatment (ET)
Number of subjects: 20
Study 35679810 — intervention group
Group type: EXPERIMENTAL
Intervention: Dehydration + Treatment (DT)
Number of subjects: 20
Study 35679810 — intervention group
Group type: COMPARATOR
Intervention: Dehydration + Control (DC)
Number of subjects: 20
Study 35679810 — intervention group
Group type: COMPARATOR
Intervention: Euhydration + Control (EC)
Number of subjects: 20
Study 35679810 — intervention group
Group type: EXPERIMENTAL
Intervention: Water supplementation
Number of subjects: 20
Study 32573729 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision tree analysis based on hemogram (white blood cell, hemoglobin, and platelet)
Number of subjects: 40395
Study 35642163 — intervention group
Group type: EXPERIMENTAL
Intervention: Algorithm segmentation based on watershed and regional growth algorithm
Number of subjects: 152
Study 35642163 — intervention group
Group type: COMPARATOR
Intervention: Manual segmentation (gold standard)
Number of subjects: 152
Study 35642163 — intervention group
Group type: COMPARATOR
Intervention: Tada formula (traditional)
Number of subjects: 152
Study 35642163 — intervention group
Group type: COMPARATOR
Intervention: Accurate Tada formula (based on 3D-Slicer)
Number of subjects: 152
Study 33975745 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual Abstracts (VAs)
Number of subjects: 20
Study 33975745 — intervention group
Group type: COMPARATOR
Intervention: Plain-text tweets
Number of subjects: 20
Study 33216026 — intervention group
Group type: EXPERIMENTAL
Intervention: SOUL-P intervention (15 intensive sessions over 6 months and 6 maintenance sessions over 6 months)
Number of subjects: 218
Study 33216026 — intervention group
Group type: EXPERIMENTAL
Intervention: SOUL-P intervention
Number of subjects: 218
Study 33216026 — intervention group
Group type: COMPARATOR
Intervention: Control group (similar number of sessions by community nurses)
Number of subjects: 218
Study 32191943 — intervention group
Group type: EXPERIMENTAL
Intervention: Graphical risk estimate
Number of subjects: 30
Study 32191943 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal risk estimate
Number of subjects: 30
Study 32191943 — intervention group
Group type: EXPERIMENTAL
Intervention: GRMT interest
Number of subjects: 30
Study 32191943 — intervention group
Group type: EXPERIMENTAL
Intervention: GRMT impact on decision-making
Number of subjects: 30
Study 36317082 — intervention group
Group type: EXPERIMENTAL
Intervention: AAT + CAT
Number of subjects: 92
Study 36317082 — intervention group
Group type: COMPARATOR
Intervention: CAT
Number of subjects: 92
Study 33579327 — intervention group
Group type: EXPERIMENTAL
Intervention: PDD-assisted en bloc transurethral resection (PDD-EBTUR)
Number of subjects: 160
Study 33579327 — intervention group
Group type: COMPARATOR
Intervention: PDD-assisted conventional transurethral resection (PDD-cTURBT)
Number of subjects: 160
Study 35587417 — intervention group
Group type: EXPERIMENTAL
Intervention: unsystematic variability
Number of subjects: 3
Study 35587417 — intervention group
Group type: COMPARATOR
Intervention: systematic variability
Number of subjects: 3
Study 35587417 — intervention group
Group type: COMPARATOR
Intervention: no variability (still image)
Number of subjects: 3
Study 33691280 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible orthoses (reduced arch thickness)
Number of subjects: 23
Study 33691280 — intervention group
Group type: EXPERIMENTAL
Intervention: Footwear only
Number of subjects: 23
Study 33691280 — intervention group
Group type: COMPARATOR
Intervention: Standard orthoses
Number of subjects: 23
Study 33569574 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive anti-hypertensive therapy
Number of subjects: 1881
Study 33569574 — intervention group
Group type: COMPARATOR
Intervention: Standard anti-hypertensive therapy
Number of subjects: 1881
Study 32074335 — intervention group
Group type: EXPERIMENTAL
Intervention: Calmare Scrambler Therapy (ST)
Number of subjects: 47
Study 32074335 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 47
Study 34958174 — intervention group
Group type: EXPERIMENTAL
Intervention: VX-128 (300 mg single dose)
Number of subjects: 26
Study 34958174 — intervention group
Group type: EXPERIMENTAL
Intervention: VX-128 (100 mg once daily for up to 10 days)
Number of subjects: 26
Study 34958174 — intervention group
Group type: EXPERIMENTAL
Intervention: VX-128 (multiple doses)
Number of subjects: 26
Study 34958174 — intervention group
Group type: EXPERIMENTAL
Intervention: VX-128 (10 mg once daily)
Number of subjects: 26
Study 34958174 — intervention group
Group type: EXPERIMENTAL
Intervention: VX-128 (10 and 30 mg once daily)
Number of subjects: 26
Study 34958174 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 32818475 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal physical therapy
Number of subjects: 212
Study 32818475 — intervention group
Group type: COMPARATOR
Intervention: Topical lidocaine (5% ointment)
Number of subjects: 212
Study 36184997 — intervention group
Group type: EXPERIMENTAL
Intervention: CyberKnife hypofractionated radiotherapy (25 Gy delivered in five fractions)
Number of subjects: 74
Study 36184997 — intervention group
Group type: COMPARATOR
Intervention: Conventional fractionated radiotherapy (up to 36 Gy)
Number of subjects: 74
Study 36184997 — intervention group
Group type: EXPERIMENTAL
Intervention: CyberKnife hypofractionated radiotherapy
Number of subjects: 74
Study 36184997 — intervention group
Group type: COMPARATOR
Intervention: Conventional fractionated radiotherapy
Number of subjects: 74
Study 34222273 — intervention group
Group type: EXPERIMENTAL
Intervention: Assigned treatments that match patient expectations
Number of subjects: 0
Study 34222273 — intervention group
Group type: EXPERIMENTAL
Intervention: Assigned treatments that do not match patient expectations
Number of subjects: 0
Study 34222273 — intervention group
Group type: COMPARATOR
Intervention: Randomisation process
Number of subjects: 0
Study 35365509 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorescence Guided Bowel Anastomosis
Number of subjects: 978
Study 35365509 — intervention group
Group type: COMPARATOR
Intervention: Conventional Bowel Anastomosis
Number of subjects: 978
Study 32259297 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic distal pancreatectomy (LDP)
Number of subjects: 60
Study 32259297 — intervention group
Group type: COMPARATOR
Intervention: Open distal pancreatectomy (ODP)
Number of subjects: 60
Study 34727185 — intervention group
Group type: EXPERIMENTAL
Intervention: One night of sleep deprivation
Number of subjects: 42
Study 34727185 — intervention group
Group type: COMPARATOR
Intervention: 9 hours of sleep
Number of subjects: 42
Study 33846506 — intervention group
Group type: EXPERIMENTAL
Intervention: Cascade convolutional neural net (CNN) for automated cephalometric analysis
Number of subjects: 1000
Study 33846506 — intervention group
Group type: COMPARATOR
Intervention: Orthodontist's manual measurement
Number of subjects: 1000
Study 33846506 — intervention group
Group type: COMPARATOR
Intervention: ROI detection using RetinaNet
Number of subjects: 1000
Study 34837524 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed (30 g/day) plus regular diet (RF group)
Number of subjects: 120
Study 34837524 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed (30 g/day) plus anti-inflammatory diet (AIF group)
Number of subjects: 120
Study 34837524 — intervention group
Group type: COMPARATOR
Intervention: Roasted wheat (30 g/day) plus regular diet (RW group)
Number of subjects: 120
Study 34737472 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-referral and clinic welcome programme
Number of subjects: 116
Study 34737472 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-referral and clinic welcome programme with training in youth-friendly service provision
Number of subjects: 116
Study 34737472 — intervention group
Group type: COMPARATOR
Intervention: Control group (56 clinics)
Number of subjects: 116
Study 35014958 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitbit Flex and automated SMS text messages
Number of subjects: 44
Study 35014958 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 44
Study 32420349 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal gel based on carboxy‐methyl‐beta‐glucan (1 application/day for 20 days per month for 3 months)
Number of subjects: 784
Study 32420349 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 784
Study 35222072 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity Inspiratory Muscle Training (IMT)
Number of subjects: 41
Study 35222072 — intervention group
Group type: COMPARATOR
Intervention: Sham low-intensity Inspiratory Muscle Training (IMT)
Number of subjects: 41
Study 34080237 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg curcuminoids daily for 7 days
Number of subjects: 62
Study 34080237 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 35981633 — intervention group
Group type: EXPERIMENTAL
Intervention: FDA bioequivalence approach
Number of subjects: 36
Study 35981633 — intervention group
Group type: COMPARATOR
Intervention: EMA bioequivalence approach
Number of subjects: 36
Study 33759909 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonoscopic polypectomy without discontinuation of antithrombotic medication
Number of subjects: 94
Study 33759909 — intervention group
Group type: COMPARATOR
Intervention: Colonoscopic polypectomy after discontinuation of antithrombotic medication
Number of subjects: 94
Study 32702245 — intervention group
Group type: EXPERIMENTAL
Intervention: Galcanezumab
Number of subjects: 0
Study 32702245 — intervention group
Group type: COMPARATOR
Intervention: Fremanezumab
Number of subjects: 0
Study 35383074 — intervention group
Group type: EXPERIMENTAL
Intervention: Family presence during CPR (n=160)
Number of subjects: 1085
Study 35383074 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=158)
Number of subjects: 1085